nodes	percent_of_prediction	percent_of_DWPC	metapath
Cytarabine—hematologic cancer—muscle cancer	0.646	1	CtDrD
Cytarabine—ABCC10—Vincristine—muscle cancer	0.0888	0.304	CbGbCtD
Cytarabine—ABCC10—Etoposide—muscle cancer	0.0814	0.279	CbGbCtD
Cytarabine—ABCC10—Doxorubicin—muscle cancer	0.0555	0.19	CbGbCtD
Cytarabine—ABCC10—Methotrexate—muscle cancer	0.0538	0.184	CbGbCtD
Cytarabine—CYP3A4—Vincristine—muscle cancer	0.00496	0.017	CbGbCtD
Cytarabine—CYP3A4—Etoposide—muscle cancer	0.00454	0.0156	CbGbCtD
Cytarabine—CYP3A4—Doxorubicin—muscle cancer	0.0031	0.0106	CbGbCtD
Cytarabine—POLD1—Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)—PMS2—muscle cancer	0.00209	0.15	CbGpPWpGaD
Cytarabine—POLD1—Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)—PMS2—muscle cancer	0.00209	0.15	CbGpPWpGaD
Cytarabine—POLD1—MMR—PMS2—muscle cancer	0.00198	0.143	CbGpPWpGaD
Cytarabine—POLA1—Vinblastine—Vincristine—muscle cancer	0.0014	0.776	CbGdCrCtD
Cytarabine—DCTD—smooth muscle tissue—muscle cancer	0.00139	0.03	CbGeAlD
Cytarabine—NT5E—embryo—muscle cancer	0.00137	0.0295	CbGeAlD
Cytarabine—POLD1—renal system—muscle cancer	0.00135	0.0293	CbGeAlD
Cytarabine—POLE—embryo—muscle cancer	0.00134	0.0289	CbGeAlD
Cytarabine—DCTD—renal system—muscle cancer	0.00134	0.0289	CbGeAlD
Cytarabine—POLB—bone marrow—muscle cancer	0.00125	0.0271	CbGeAlD
Cytarabine—POLB—vagina—muscle cancer	0.0012	0.026	CbGeAlD
Cytarabine—DCTD—cardiac atrium—muscle cancer	0.0012	0.0259	CbGeAlD
Cytarabine—POLB—head—muscle cancer	0.00111	0.024	CbGeAlD
Cytarabine—POLB—DNA Repair—PMS2—muscle cancer	0.00108	0.0779	CbGpPWpGaD
Cytarabine—NT5E—smooth muscle tissue—muscle cancer	0.00107	0.0232	CbGeAlD
Cytarabine—POLB—testis—muscle cancer	0.00107	0.0232	CbGeAlD
Cytarabine—DCTD—tendon—muscle cancer	0.00104	0.0226	CbGeAlD
Cytarabine—NT5E—renal system—muscle cancer	0.00103	0.0224	CbGeAlD
Cytarabine—DCTD—bone marrow—muscle cancer	0.00101	0.0219	CbGeAlD
Cytarabine—DCTD—vagina—muscle cancer	0.000967	0.0209	CbGeAlD
Cytarabine—CDA—tendon—muscle cancer	0.000949	0.0205	CbGeAlD
Cytarabine—NT5E—cardiac atrium—muscle cancer	0.000925	0.02	CbGeAlD
Cytarabine—CDA—bone marrow—muscle cancer	0.000919	0.0199	CbGeAlD
Cytarabine—POLD1—head—muscle cancer	0.000906	0.0196	CbGeAlD
Cytarabine—DCTD—head—muscle cancer	0.000894	0.0193	CbGeAlD
Cytarabine—CDA—vagina—muscle cancer	0.00088	0.0191	CbGeAlD
Cytarabine—POLD1—testis—muscle cancer	0.000875	0.0189	CbGeAlD
Cytarabine—DCTD—testis—muscle cancer	0.000863	0.0187	CbGeAlD
Cytarabine—NT5E—tendon—muscle cancer	0.000807	0.0175	CbGeAlD
Cytarabine—POLE—tendon—muscle cancer	0.00079	0.0171	CbGeAlD
Cytarabine—CDA—testis—muscle cancer	0.000785	0.017	CbGeAlD
Cytarabine—NT5E—bone marrow—muscle cancer	0.000781	0.0169	CbGeAlD
Cytarabine—POLE—bone marrow—muscle cancer	0.000765	0.0166	CbGeAlD
Cytarabine—NT5E—vagina—muscle cancer	0.000748	0.0162	CbGeAlD
Cytarabine—POLE—vagina—muscle cancer	0.000733	0.0159	CbGeAlD
Cytarabine—DCK—embryo—muscle cancer	0.000711	0.0154	CbGeAlD
Cytarabine—NT5E—head—muscle cancer	0.000691	0.015	CbGeAlD
Cytarabine—POLA1—tendon—muscle cancer	0.000681	0.0147	CbGeAlD
Cytarabine—POLE—head—muscle cancer	0.000677	0.0147	CbGeAlD
Cytarabine—NT5E—testis—muscle cancer	0.000668	0.0145	CbGeAlD
Cytarabine—POLA1—bone marrow—muscle cancer	0.00066	0.0143	CbGeAlD
Cytarabine—POLE—testis—muscle cancer	0.000654	0.0142	CbGeAlD
Cytarabine—SLC22A2—renal system—muscle cancer	0.000649	0.0141	CbGeAlD
Cytarabine—POLA1—vagina—muscle cancer	0.000632	0.0137	CbGeAlD
Cytarabine—POLA1—testis—muscle cancer	0.000564	0.0122	CbGeAlD
Cytarabine—SLC29A1—renal system—muscle cancer	0.000563	0.0122	CbGeAlD
Cytarabine—POLA1—E2F transcription factor network—TFE3—muscle cancer	0.000558	0.0401	CbGpPWpGaD
Cytarabine—ABCC10—renal system—muscle cancer	0.000512	0.0111	CbGeAlD
Cytarabine—SLC29A1—cardiac atrium—muscle cancer	0.000504	0.0109	CbGeAlD
Cytarabine—DCK—cardiac atrium—muscle cancer	0.000482	0.0104	CbGeAlD
Cytarabine—ABCC10—cardiac atrium—muscle cancer	0.000459	0.00993	CbGeAlD
Cytarabine—SLC22A1—renal system—muscle cancer	0.000459	0.00993	CbGeAlD
Cytarabine—SLC29A1—tendon—muscle cancer	0.00044	0.00951	CbGeAlD
Cytarabine—SLC29A1—bone marrow—muscle cancer	0.000426	0.00921	CbGeAlD
Cytarabine—NT5E—Differentiation Pathway—KIT—muscle cancer	0.000421	0.0302	CbGpPWpGaD
Cytarabine—DCK—tendon—muscle cancer	0.00042	0.00909	CbGeAlD
Cytarabine—POLD1—DNA Repair—PMS2—muscle cancer	0.000415	0.0298	CbGpPWpGaD
Cytarabine—SLC29A1—vagina—muscle cancer	0.000408	0.00883	CbGeAlD
Cytarabine—DCK—bone marrow—muscle cancer	0.000407	0.0088	CbGeAlD
Cytarabine—DCK—Epirubicin—Doxorubicin—muscle cancer	0.000404	0.224	CbGdCrCtD
Cytarabine—POLE—DNA Repair—PMS2—muscle cancer	0.000401	0.0288	CbGpPWpGaD
Cytarabine—ABCC10—tendon—muscle cancer	0.0004	0.00866	CbGeAlD
Cytarabine—DCK—vagina—muscle cancer	0.00039	0.00843	CbGeAlD
Cytarabine—ABCC10—bone marrow—muscle cancer	0.000387	0.00839	CbGeAlD
Cytarabine—SLC29A1—head—muscle cancer	0.000377	0.00815	CbGeAlD
Cytarabine—POLA1—E2F transcription factor network—TP73—muscle cancer	0.000377	0.0271	CbGpPWpGaD
Cytarabine—ABCC10—vagina—muscle cancer	0.000371	0.00803	CbGeAlD
Cytarabine—SLC29A1—testis—muscle cancer	0.000364	0.00788	CbGeAlD
Cytarabine—DCK—head—muscle cancer	0.00036	0.00779	CbGeAlD
Cytarabine—DCK—testis—muscle cancer	0.000348	0.00753	CbGeAlD
Cytarabine—SLC22A1—vagina—muscle cancer	0.000332	0.00719	CbGeAlD
Cytarabine—ABCC10—testis—muscle cancer	0.000331	0.00717	CbGeAlD
Cytarabine—SLC22A1—head—muscle cancer	0.000307	0.00664	CbGeAlD
Cytarabine—NT5E—Differentiation Pathway—VEGFA—muscle cancer	0.000252	0.0181	CbGpPWpGaD
Cytarabine—CDA—Fluoropyrimidine Activity—TP53—muscle cancer	0.000235	0.0169	CbGpPWpGaD
Cytarabine—CYP3A4—renal system—muscle cancer	0.000209	0.00452	CbGeAlD
Cytarabine—NT5E—HIF-1-alpha transcription factor network—VEGFA—muscle cancer	0.000195	0.014	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—FH—muscle cancer	0.000191	0.0137	CbGpPWpGaD
Cytarabine—SLC29A1—Fluoropyrimidine Activity—TP53—muscle cancer	0.000163	0.0117	CbGpPWpGaD
Cytarabine—POLE—G1 to S cell cycle control—CDKN2A—muscle cancer	0.000142	0.0102	CbGpPWpGaD
Cytarabine—POLE—G1 to S cell cycle control—MDM2—muscle cancer	0.000137	0.00988	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	0.000132	0.00951	CbGpPWpGaD
Cytarabine—POLE—Retinoblastoma (RB) in Cancer—MDM2—muscle cancer	0.000113	0.00811	CbGpPWpGaD
Cytarabine—DCK—Retinoblastoma (RB) in Cancer—MDM2—muscle cancer	0.00011	0.00789	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—FH—muscle cancer	0.00011	0.00788	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—MED12—muscle cancer	0.000108	0.00776	CbGpPWpGaD
Cytarabine—CDA—Metabolism—FH—muscle cancer	0.0001	0.00721	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—ENO2—muscle cancer	9.84e-05	0.00707	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	9.67e-05	0.00695	CbGpPWpGaD
Cytarabine—POLA1—E2F transcription factor network—CDKN2A—muscle cancer	9.54e-05	0.00686	CbGpPWpGaD
Cytarabine—POLE—Mitotic M-M/G1 phases—BUB1B—muscle cancer	8.79e-05	0.00631	CbGpPWpGaD
Cytarabine—POLE—Mitotic G1-G1/S phases—CDKN2A—muscle cancer	8.19e-05	0.00588	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—MDM2—muscle cancer	8.04e-05	0.00578	CbGpPWpGaD
Cytarabine—POLE—G1 to S cell cycle control—TP53—muscle cancer	7.89e-05	0.00567	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—BUB1B—muscle cancer	6.8e-05	0.00489	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—BUB1B—muscle cancer	6.57e-05	0.00472	CbGpPWpGaD
Cytarabine—POLE—Retinoblastoma (RB) in Cancer—TP53—muscle cancer	6.47e-05	0.00465	CbGpPWpGaD
Cytarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—muscle cancer	6.3e-05	0.00453	CbGpPWpGaD
Cytarabine—POLA1—Mitotic M-M/G1 phases—BUB1B—muscle cancer	6.26e-05	0.0045	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—FH—muscle cancer	6.22e-05	0.00447	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—MED12—muscle cancer	6.2e-05	0.00445	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—BUB1B—muscle cancer	6.08e-05	0.00437	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—BUB1B—muscle cancer	5.88e-05	0.00422	CbGpPWpGaD
Cytarabine—DCK—Metabolism—FH—muscle cancer	5.85e-05	0.0042	CbGpPWpGaD
Cytarabine—POLA1—Mitotic G1-G1/S phases—CDKN2A—muscle cancer	5.83e-05	0.00419	CbGpPWpGaD
Cytarabine—CDA—Metabolism—MED12—muscle cancer	5.67e-05	0.00407	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—ENO2—muscle cancer	5.65e-05	0.00406	CbGpPWpGaD
Cytarabine—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	5.43e-05	0.0039	CbGpPWpGaD
Cytarabine—CDA—Metabolism—ENO2—muscle cancer	5.17e-05	0.00371	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—BUB1B—muscle cancer	4.68e-05	0.00336	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—muscle cancer	4.61e-05	0.00332	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	4.29e-05	0.00308	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—BUB1B—muscle cancer	4.19e-05	0.00301	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	4.13e-05	0.00297	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—MED12—muscle cancer	3.52e-05	0.00253	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PTGS2—muscle cancer	3.43e-05	0.00246	CbGpPWpGaD
Cytarabine—DCK—Metabolism—MED12—muscle cancer	3.31e-05	0.00238	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	3.25e-05	0.00234	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—ENO2—muscle cancer	3.21e-05	0.0023	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—CDKN2A—muscle cancer	3.11e-05	0.00223	CbGpPWpGaD
Cytarabine—DCK—Metabolism—ENO2—muscle cancer	3.01e-05	0.00217	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—CDKN2A—muscle cancer	3e-05	0.00216	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—CDKN2A—muscle cancer	2.78e-05	0.002	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—MDM2—muscle cancer	2.7e-05	0.00194	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—CDKN2A—muscle cancer	2.68e-05	0.00193	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—MDM2—muscle cancer	2.6e-05	0.00187	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	2.46e-05	0.00177	CbGpPWpGaD
Cytarabine—CYP3A4—Tryptophan metabolism—MDM2—muscle cancer	2.44e-05	0.00175	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—FH—muscle cancer	2.32e-05	0.00167	CbGpPWpGaD
Cytarabine—SLC22A2—Transmission across Chemical Synapses—MDM2—muscle cancer	2.24e-05	0.00161	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—FH—muscle cancer	2.16e-05	0.00155	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—CDKN2A—muscle cancer	2.14e-05	0.00154	CbGpPWpGaD
Cytarabine—SLC22A1—Transmission across Chemical Synapses—MDM2—muscle cancer	2.08e-05	0.0015	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PTGS2—muscle cancer	1.97e-05	0.00141	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—CDKN2A—muscle cancer	1.91e-05	0.00137	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—MDM2—muscle cancer	1.86e-05	0.00133	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PTGS2—muscle cancer	1.8e-05	0.00129	CbGpPWpGaD
Cytarabine—SLC22A2—Neuronal System—MDM2—muscle cancer	1.71e-05	0.00123	CbGpPWpGaD
Cytarabine—SLC22A1—Neuronal System—MDM2—muscle cancer	1.6e-05	0.00115	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—TP53—muscle cancer	1.55e-05	0.00111	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—TP53—muscle cancer	1.49e-05	0.00107	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—MED12—muscle cancer	1.31e-05	0.000941	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—MED12—muscle cancer	1.22e-05	0.000877	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—ENO2—muscle cancer	1.19e-05	0.000858	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PTGS2—muscle cancer	1.12e-05	0.000802	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—ENO2—muscle cancer	1.11e-05	0.0008	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—TP53—muscle cancer	1.06e-05	0.000765	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PTGS2—muscle cancer	1.05e-05	0.000754	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—FH—muscle cancer	7.8e-06	0.000561	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—MED12—muscle cancer	4.41e-06	0.000317	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PTGS2—muscle cancer	4.16e-06	0.000299	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—ENO2—muscle cancer	4.02e-06	0.000289	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PTGS2—muscle cancer	3.88e-06	0.000279	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PTGS2—muscle cancer	1.4e-06	0.000101	CbGpPWpGaD
